Snippet from the article:
Follica has raised more money for its quest against hair follicle disorders like male pattern baldness. The biotech startup, which is developing drugs that could spur the formation of new hair follicles, has raised $7.5 million in equity financing, according to an SEC filing.
Read the rest at Xconomy.com — Follica, the Biotech With Potential Drug Against Baldness, Nabs $7.5M Venture Financing
Follica is still in the development phase, so there’s no telling if this will end up working as well as many folks on the internet hope. The company’s policy is to not comment on their research and development, but the article at Xconomy.com does provide more insight into the venture capitalists that are funding it.